Reconstituted liquid CJC-1295 No DAC (Modified GRF 1-29) exhibits rapid peptide backbone cleavage when subjected to repeated freeze-thaw cycles. In laboratory settings, maintaining a liquid peptide solution through multiple temperature oscillations increases aggregation and loss of secondary structure. Lyophilized aliquoting prior to reconstitution or single-use liquid aliquot storage at -20°C prevents enzymatic and physical degradation.
Reconstituted liquid CJC-1295 No DAC (Modified GRF 1-29) exhibits rapid peptide backbone cleavage when subjected to repeated freeze-thaw cycles. In laboratory settings, maintaining a liquid peptide solution through multiple temperature oscillations increases aggregation and loss of secondary structure. Lyophilized aliquoting prior to reconstitution or single-use liquid aliquot storage at -20°C prevents enzymatic and physical degradation.
CJC-1295 No DAC, also known as Modified GRF 1-29, is a synthetic 29-amino-acid peptide analog of human growth hormone-releasing hormone (GHRH). It incorporates four amino acid substitutions (D-Ala2, Gln8, Ala15, and Leu27) designed to improve resistance against enzymatic cleavage by dipeptidyl peptidase IV (DPP-IV). When evaluated as a GHRH analog, the un-complexed peptide is studied as a long-acting growth-hormone-releasing hormone that sustains GH and downstream IGF-1 levels for tissue repair research.
In its lyophilized state, the solid peptide matrix maintains high chemical stability due to minimal moisture content. However, once converted into a liquid solution via reconstitution, the peptide backbone becomes vulnerable to hydrolysis, oxidation of methionine residues, and deamidation of asparagine residues. Understanding how a liquid peptide behaves under thermal stress is critical for maintaining experimental reproducibility across cell-culture and animal model assays.
Subjecting a liquid peptide solution to repeated freeze-thaw cycles subjects the dissolved molecules to ice crystal nucleation, cryoconcentration, and local pH changes. As water freezes into ice crystals, dissolved CJC-1295 No DAC molecules are excluded from the ice matrix into interstitial micro-domains of hyper-concentrated solute. This localized concentration drastically increases the rate of intermolecular aggregation.
Furthermore, mechanical shear stress induced by ice crystal expansion breaks weak non-covalent bonds holding the peptide's secondary structure. Upon thawing, aggregated or cleaved fragments do not reliably refold into active conformations. Research indicates that after as few as three freeze-thaw cycles, a reconstituted liquid sample can show a measurable decline in chromatographic purity, altering receptor-binding kinetics in laboratory assays.
Evaluating structural degradation across secretagogues requires comparing CJC-1295 No DAC against similar synthetic peptides in aqueous media. While CJC-1295 No DAC lacks the Drug Affinity Complex (DAC) reactive group that binds albumin in vivo, its chemical stability profile differs substantially from both long-acting variants and truncated GH secretagogues.
In head-to-head stability testing within laboratory solutions, compounds exhibit distinct degradation rates under freeze-thaw conditions:
• CJC-1295 With DAC: The Maleimidopropionic acid (MPA) linker adds steric bulk, slightly lowering susceptibility to micro-shear during freezing, though liquid stocks still suffer from hydrolysis over time. • Sermorelin: Containing the native GHRH 1-29 sequence without D-amino acid substitutions, Sermorelin degrades faster in liquid solution when exposed to temperature fluctuations compared to CJC-1295 No DAC. • Ipamorelin: As a pentapeptide growth hormone secretagogue, Ipamorelin displays greater structural rigidity in liquid solution than longer GHRH chain analogs, though it remains prone to oxidation if improperly stored. • BPC-157: Although classified as a gastric pentadecapeptide rather than a GHRH analog, BPC-157 is frequently analyzed alongside growth factors in tissue repair research due to its stability in aqueous solutions across broader pH ranges.
The following matrix summarizes key stability parameters for laboratory research planning:
To ensure that observed experimental outcomes stem from pristine molecular activity rather than degraded fragments or bacterial contamination, research laboratories must enforce strict procurement criteria. Every batch of CJC-1295 No DAC utilized in physical chemistry or cell culture experiments should be sourced from verified domestic manufacturing operations.
PX1 Research enforces comprehensive analytical validation on every lot before dispatch:
1. High-Performance Liquid Chromatography (HPLC): Guarantees chemical purity exceeds 99.0%, identifying and quantifying any trace manufacturing impurities. 2. Mass Spectrometry (MS): Verifies exact molecular mass to confirm identity and absence of truncated sequences. 3. Endotoxin Testing: Assays confirm endotoxin levels are under 0.01 EU/mg, preventing unspecific immune signaling in sensitive in vitro and preclinical models. 4. USA Manufacturing & ISO 17025 Testing: Synthesized in GMP-compliant facilities within the USA and verified by independent accredited laboratories. 5. Lot-Specific Traceability: Complete batch records and third-party Certificate of Analysis (COA) included with every shipment, dispatched same-day M–F from facilities in California and Arizona.
Proper reconstitution is the primary line of defense against premature peptide degradation. Investigators should utilize sterile, unpreserved 0.9% Sodium Chloride or Bacteriostatic Water containing 0.9% Benzyl Alcohol, depending on the intended duration of the liquid stock. Benzyl alcohol acts as a bacteriostatic agent, retarding microbial proliferation during storage at 2°C to 8°C.
When introducing diluent to the lyophilized vial, direct high-pressure liquid streams onto the cake should be avoided. Instead, allow the liquid to flow gently down the interior glass wall. Reconstitution should be assisted by gentle swirling rather than vigorous vortexing, as mechanical agitation causes surface-induced denaturation and foaming in liquid peptide solutions. For complete step-by-step volumetric guidelines, refer to the PX1 peptide reconstitution calculator.
Chemical breakdown of CJC-1295 No DAC in liquid media proceeds through distinct pathways dictated by pH, temperature, and light exposure:
• Deamidation: Asparagine residues degrade into isoaspartic acid variants, particularly in neutral to alkaline liquid buffers. • Oxidation: Methionine residues exposed to dissolved oxygen in liquid media convert into methionine sulfoxide, altering tertiary docking capability. • Hydrolysis: Cleavage of peptide bonds occurs over prolonged liquid storage, accelerated by temperatures above 4°C. • Aggregation: Non-covalent association of hydrophobic domains forms insoluble fibril networks during liquid thermal cycling.
Maintaining liquid aliquots at sub-zero temperatures prevents hydrolysis but introduces freeze-thaw stress. Consequently, research protocols must balance liquid shelf-life against the mechanical damage of phase transitions.
To maximize the utility of reconstituted liquid CJC-1295 No DAC without sacrificing experimental precision, laboratories should implement a single-use aliquoting protocol. Once the lyophilized powder is fully dissolved into a liquid state, immediately divide the solution into micro-aliquots using sterile, low-binding polypropylene tubes.
Each liquid aliquot should contain only the volume required for a single experimental run or day of testing. Freeze these aliquots immediately at -20°C or -80°C. When an assay is performed, thaw a single aliquot at room temperature or 4°C, use the required liquid immediately, and discard any remainder. This protocol entirely eliminates repeated freeze-thaw cycles for the primary stock, safeguarding structural integrity.
For broader guidelines on handling sensitive peptides in analytical environments, explore the PX1 research library hub or review protocols for lyophilized vs liquid peptide stability.
High-throughput screening laboratories and academic institutions conducting large-scale preclinical trials require consistent lot-to-lot purity to maintain long-term baseline controls. Variations in synthesis efficiency or freeze-dried cake moisture levels can yield inconsistent liquid stability profiles upon reconstitution.
PX1 Research supports institutional procurement through dedicated wholesale lab account structures. Bulk orders undergo identical analytical rigor, ensuring every vial of CJC-1295 No DAC delivers uniform solubility, verified sequence accuracy, and low endotoxin burdens suitable for rigorous scientific investigation.
What happens to liquid CJC-1295 No DAC when frozen and thawed repeatedly?
Repeated freeze-thaw cycles subject liquid CJC-1295 No DAC to ice crystal nucleation and cryoconcentration. This mechanical and chemical stress promotes peptide cleavage, aggregation, and irreversible loss of bioactive secondary structure.
How long does a liquid CJC-1295 No DAC solution remain stable at 4°C?
Reconstituted liquid CJC-1295 No DAC stored in bacteriostatic water at 4°C typically remains stable for up to 14 to 21 days before hydrolysis and deamidation lead to measurable purity loss on RP-HPLC.
Can liquid CJC-1295 No DAC be stored at -80°C without loss of integrity?
Yes, liquid aliquots stored at -80°C maintain long-term stability, provided they undergo only one single thaw cycle immediately prior to assay execution.
What is the key difference between liquid CJC-1295 No DAC and lyophilized powder?
Lyophilized CJC-1295 No DAC is a freeze-dried solid matrix stripped of moisture, offering high resistance to degradation. Liquid CJC-1295 No DAC is the reconstituted solution, which is significantly more vulnerable to thermal, enzymatic, and pH-driven breakdown.
How does freeze-thaw frequency affect RP-HPLC purity profiles?
Each freeze-thaw cycle typically increases the presence of secondary peak shoulders on RP-HPLC chromatograms, corresponding to aggregated species and hydrolysis fragments, thereby lowering main-peak purity percentage.
Is bacteriostatic water recommended for reconstituted liquid stock?
Yes, bacteriostatic water containing 0.9% benzyl alcohol is recommended for liquid stock intended for multi-day laboratory use at 4°C to prevent bacterial growth.
How do DAC modifications impact liquid freeze-thaw stability?
The Drug Affinity Complex (DAC) modification adds steric bulk that slightly alters solution behavior, but both DAC and No DAC variants suffer structural degradation if subjected to repeated freeze-thaw cycles in liquid form.
Why is endotoxin testing critical for liquid peptide solutions in vitro?
Endotoxins (LPS) in liquid research solutions can trigger unwanted inflammatory pathways in cell cultures and animal models, confounding experimental data regarding GHRH signaling and tissue repair.
How should laboratory aliquots of liquid GHRH analogs be prepared?
Reconstituted liquid peptides should be divided immediately into single-use low-binding polypropylene vials sized for single experimental runs and stored at -20°C or -80°C to eliminate repeated thawing.
Where can research facilities order high-purity CJC-1295 No DAC with third-party COAs?
PX1 Research supplies USA-manufactured CJC-1295 No DAC featuring HPLC/MS identity verification, endotoxin testing, and lot-specific COAs, shipped same-day M–F from CA and AZ.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.